More news
Three works led by the ICREA investigator Dr. Josep Dalmau among the 25 Lancet Neurology most cited papers
Dr. Josep Dalmau is an ICREA investigator leading the IDIBAPS Autoimmunity against synaptic antigens Group. His international impact is reflected in1
Early treatment of patients with asymptomatic myeloma delays disease progression
Early treatment of asymptomatic high-risk smoldering myeloma could significantly improve the course of disease, slowing its progression and significa1
CLIF Consortium describes a new syndrome in patients with acute decompensation of cirrhosis
Chronic liver failure is among the top ten causes of death in adults in many countries and constitutes the most common reason for hospital admission1
The Clinical and Experimental Respiratory Immunoallergy team receives two presentation awards at the EAACI-WAO Congress
Two members of the IDIBAPS Clinical and Experimental Respiratory Immunoallergy team (IRCE), the predoctoral researcher Francisco de Borja Callejas Dí1
A IDIBAPS-IIBB-CSIC team proposes a potential biomarker for early diagnosis of Alzheimer's disease
The search for a reliable way to diagnose Alzheimer's disease is one of the great challenges of modern biomedicine. IDIBAPS-IIBB-CSIC Neurobiology Un1
IDIBAPS gives support to its foreign researchers when they arrive to Barcelona through the Barcelona Centre Universitari (BCU)
Catalonia is becoming one of the main knowledge centers in the Mediterranean. To facilitate this process, Barcelona Centre Universitari (BCU) helps f1
A triple therapy increases the sustained virological response in patients co-infected with HIV and hepatitis C virus
About a third of people infected with HIV in the USA and Europe are also infected with hepatitis C virus (HCV). A work published in The Lancet Infect1
Two IDIBAPS works among the Gastroenterology most cited articles between 2009-2012
Gastroenterology is the premiere journal in the field of gastroenterology and hepatology. It recently published a ranking of the top 10 most cited ar1